TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21445665

Group type: EXPERIMENTAL
Intervention: Guitar timbre exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marimba timbre exposure
Number of subjects: 0
Study: 19361802

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 16287900

Group type: COMPARATOR
Intervention: Standard laryngoscope
Number of subjects: 32

Group type: COMPARATOR
Intervention: Disposable laryngoscope
Number of subjects: 32

Group type: COMPARATOR
Intervention: Covered laryngoscope
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Covered laryngoscope vs Disposable laryngoscope
Number of subjects: 32
Study: 15163505

Group type: EXPERIMENTAL
Intervention: Monovalent aluminum-adjuvanted whole virus formulations with 1.9 microg HA per dose
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Monovalent aluminum-adjuvanted whole virus formulations with 3.75 microg HA per dose
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Monovalent aluminum-adjuvanted whole virus formulations with 7.5 microg HA per dose
Number of subjects: 200

Group type: COMPARATOR
Intervention: Split virus vaccine (15 microg HA per dose) without aluminum adjuvantation
Number of subjects: 200
Study: 11060830

Group type: EXPERIMENTAL
Intervention: Lanoteplase (120 KU/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lanoteplase
Number of subjects: 0
Study: 9059244

Group type: EXPERIMENTAL
Intervention: SLO microperimetry for detecting deep and relative scotomas in full thickness macular holes
Number of subjects: 106

Group type: COMPARATOR
Intervention: SLO microperimetry for detecting deep and relative scotomas in macular pseudoholes or impending macular holes
Number of subjects: 106
Study: 8492160

Group type: EXPERIMENTAL
Intervention: Cycling with normal, phasic ankle activity (free-form cycling)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static limb positioning with consistent SOL activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled TA cycling activity conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static limb positioning
Number of subjects: 0
Study: 2891739

Group type: EXPERIMENTAL
Intervention: Metipranolol 0.1%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Metipranolol 0.3%
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 29189291

Group type: COMPARATOR
Intervention: Epidural bupivacaine 0.125%
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine 0.2%
Number of subjects: 36
Study: 27125948

Group type: EXPERIMENTAL
Intervention: Thrombectomy
Number of subjects: 10732

Group type: COMPARATOR
Intervention: PCI alone
Number of subjects: 10732
Study: 23628627

Group type: EXPERIMENTAL
Intervention: Lower-body BFR intervention (occlusion cuff inflated to 180 mmHg)
Number of subjects: 20
Study: 22337508

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behaviour Therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 0
Study: 19430819

Group type: EXPERIMENTAL
Intervention: GP-led follow-up
Number of subjects: 18
Study: 18243585

Group type: EXPERIMENTAL
Intervention: 6-month methadone maintenance with minimal counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6-month methadone maintenance with standard counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: 21-day methadone detoxification
Number of subjects: 0
Study: 15934094

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg/day)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 14615670

Group type: EXPERIMENTAL
Intervention: Effective treatment of GERD with prolonged and aggressive antisecretory therapy
Number of subjects: 0
Study: 10387955

Group type: EXPERIMENTAL
Intervention: Ibuprofen with organic acids as excipients in enteric matrix granules (Eudragit S and Aqoat AS-HF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bioavailability tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mathematical transformation of data for individual formulations
Number of subjects: 0
Study: 8697164

Group type: EXPERIMENTAL
Intervention: Interferon-alpha
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Thymomodulin
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Interferon-alpha and Thymomodulin
Number of subjects: 38
Study: 2053717

Group type: EXPERIMENTAL
Intervention: In-service lectures for 30% of nurses and opinion leaders' tutorials for all nurses in group A
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Opinion leaders' tutorials alone in group B
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lectures alone in group C
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Direct observation practices in group A
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Direct observation practices in group B
Number of subjects: 30
Study: 7201812

Group type: EXPERIMENTAL
Intervention: Bronchoretard (350 mg theophylline in capsule)
Number of subjects: 7
Study: 30630772

Group type: EXPERIMENTAL
Intervention: R-MBVP (methotrexate-based chemotherapy with rituximab)
Number of subjects: 200

Group type: COMPARATOR
Intervention: MBVP (methotrexate-based chemotherapy without rituximab)
Number of subjects: 200

Group type: COMPARATOR
Intervention: MBVP (control group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: R-MBVP (intervention group)
Number of subjects: 200
Study: 29214526

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 30
Study: 27199494

Group type: EXPERIMENTAL
Intervention: R-T estimation using CoaguChek XS
Number of subjects: 0
Study: 24690402

Group type: EXPERIMENTAL
Intervention: Structured educational group programme incorporating psychological approaches
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Structured educational group programme
Number of subjects: 362
Study: 22350624

Group type: EXPERIMENTAL
Intervention: Clopidogrel pre-treatment within 5 days prior to surgery
Number of subjects: 596

Group type: COMPARATOR
Intervention: No clopidogrel
Number of subjects: 596
Study: 19055871

Group type: EXPERIMENTAL
Intervention: Group-mediated cognitive behavioural counselling plus exercise (GMCB)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard exercise (SE)
Number of subjects: 57
Study: 17173912

Group type: EXPERIMENTAL
Intervention: RF-NaP (40 tablets, split dosing, 3 every 15 minutes)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RF-NaP (32 tablets, split dosing, 4 every 15 minutes)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RF-NaP (28 tablets, split dosing, 4 every 15 minutes)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RF-NaP (32 tablets, evening-only dosing, 4 every 15 minutes)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: RF-NaP (28 tablets, evening-only dosing, 4 every 15 minutes)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Visicol (40 tablets, split dosing, 3 every 15 minutes)
Number of subjects: 34
Study: 15179409

Group type: EXPERIMENTAL
Intervention: High-dose hyperforin-rich extract LI 160
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 4 g Hypericum powder with comparable hyperforin content
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 2 g Hypericum powder with half the hyperforin content
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: COMPARATOR
Intervention: 2 g powder without hyperforin, tea, juice, oil extract, hyperforin-free extract (Ze 117), low daily doses of hyperforin-containing Hypericum powder (1 g, 0.5 g)
Number of subjects: 96
Study: 11472387

Group type: EXPERIMENTAL
Intervention: Metamizol 0.5 g
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Metamizol 1 g
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid 1 g
Number of subjects: 417

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 417
Study: 9684781

Group type: EXPERIMENTAL
Intervention: Genetic test for rapid screening of mutations G2811A (R854Q), C2696T (R816W), T2701A (H817Q), and G2823T (C858F) using polymerase chain reaction (PCR).
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Genetic test for rapid screening of mutations G2811A (R854Q), C2696T (R816W), T2701A (H817Q), and G2823T (C858F).
Number of subjects: 108
Study: 7850823

Group type: EXPERIMENTAL
Intervention: Plasma BNP measurement
Number of subjects: 24
Study: 3382333

Group type: EXPERIMENTAL
Intervention: Compression screw and plate fixation
Number of subjects: 201

Group type: COMPARATOR
Intervention: Ender's nails
Number of subjects: 201
Study: 29602986

Group type: EXPERIMENTAL
Intervention: Appendectomy training on the virtual reality simulator until proficiency, followed by cholecystectomy tasks.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Directly started with cholecystectomy tasks on the virtual reality simulator.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups underwent proficiency-based basic training.
Number of subjects: 44
Study: 26792707

Group type: EXPERIMENTAL
Intervention: Dynamic Integrated Movement Enhancement (DIME) injury prevention program
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Standard Warm-Up (SWU) program
Number of subjects: 1104
Study: 24615085

Group type: EXPERIMENTAL
Intervention: Tonsillectomy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Partial tonsillectomy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 57
Study: 23545707

Group type: EXPERIMENTAL
Intervention: losartan 100 mg daily
Number of subjects: 169

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 169
Study: 21490284

Group type: EXPERIMENTAL
Intervention: Endpoint visual feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No endpoint visual feedback
Number of subjects: 0
Study: 18722039

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide (CP10)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 16% carbamide peroxide (CP16)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 92
Study: 16432441

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison conditions (routine care or another treatment)
Number of subjects: 12
Study: 14640848

Group type: EXPERIMENTAL
Intervention: Manipulation of processing fluency in artificial grammar learning tasks (Experiments 1, 2, 4, and 7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluency manipulation in recognition tasks (Experiments 4-6)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition in classification tasks (Experiment 7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition decisions under identical conditions (Experiments 3 and 5)
Number of subjects: 0
Study: 11081322

Group type: EXPERIMENTAL
Intervention: Trimetazidine (3 x 20 mg/day for 24 hours prior to exercise test)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no drug administered)
Number of subjects: 16
Study: 9121852

Group type: EXPERIMENTAL
Intervention: Budesonide 600 mu g twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1537130

Group type: EXPERIMENTAL
Intervention: Pimobendan 5 mg/day
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Pimobendan 10 mg/day
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Pimobendan (all doses combined)
Number of subjects: 198
Study: 6714792

Group type: EXPERIMENTAL
Intervention: Cyclotropium bromide (60 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hyoscine N-butylbromide (60 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30426714

Group type: EXPERIMENTAL
Intervention: Fosaprepitant
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 29327602

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with gallium-aluminum-arsenide laser at 850 nm wavelength for 10 sessions, 3 times a week.
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) with 2000 shock waves at 0.02 mJ/mm2 for 3 sessions, once a week.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care (exercises and orthotic supports) only.
Number of subjects: 66
Study: 26823210

Group type: EXPERIMENTAL
Intervention: FF 100 μg in the morning (AM)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: FF 100 μg in the evening (PM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 24288077

Group type: EXPERIMENTAL
Intervention: Routine lateral retinacular release
Number of subjects: 148

Group type: COMPARATOR
Intervention: No lateral retinacular release (Control)
Number of subjects: 148
Study: 21715124

Group type: EXPERIMENTAL
Intervention: MEDIAS 2 ICT
Number of subjects: 186

Group type: COMPARATOR
Intervention: ACC (established education programme)
Number of subjects: 186
Study: 21040188

Group type: EXPERIMENTAL
Intervention: Slow up-titration with paroxetine (increments of 2.5 mg/day every 2 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard up-titration with paroxetine (increments of 10 mg/day every week)
Number of subjects: 60
Study: 18949779

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil in combination with prednisone
Number of subjects: 0
Study: 16288373

Group type: EXPERIMENTAL
Intervention: HPV-6 L2E7 vaccine with AS02A adjuvant
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 11923135

Group type: EXPERIMENTAL
Intervention: Adjuvant postoperative chemoradiotherapy
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: D0 lymphadenectomy
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Surgical treatment variation
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Cox multivariate regression analysis
Number of subjects: 553
Study: 9790393

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: Abnormal glucose tolerance
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: Plasma glucose level 1 hour after a 50-g oral glucose challenge
Number of subjects: 3689
Study: 8543750

Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula
Number of subjects: 20

Group type: COMPARATOR
Intervention: Casein hydrolysate formula
Number of subjects: 20
Study: 2242080

Group type: EXPERIMENTAL
Intervention: Transdermal insulin application
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sulfonylurea monotherapy
Number of subjects: 6
Study: 98196

Group type: EXPERIMENTAL
Intervention: Pimozide (up to 20 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorpromazine (up to 1,000 mg daily)
Number of subjects: 0
Study: 29676140

Group type: EXPERIMENTAL
Intervention: Shenqi Dihuang decoction
Number of subjects: 205
Study: 28272808

Group type: EXPERIMENTAL
Intervention: CardioMEMS HF System
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care treatment for HF
Number of subjects: 0
Study: 26275648

Group type: EXPERIMENTAL
Intervention: Polyherbal formulation (PHF) 500 mg/day, up titrated to 3 g/day
Number of subjects: 93

Group type: COMPARATOR
Intervention: Metformin 500 mg/day, up titrated to 2 g/day
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Polyherbal formulation (PHF)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 93
Study: 23811465

Group type: EXPERIMENTAL
Intervention: Herbal medicine treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 15
Study: 21073734

Group type: EXPERIMENTAL
Intervention: Functional treatment (early active motion within the limits of pain)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plaster immobilization (in 90 degrees flexion, neutral position for pro-supination for a period of three weeks)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Functional treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plaster immobilization
Number of subjects: 100
Study: 18250349

Group type: COMPARATOR
Intervention: Doxorubicin plus cyclophosphamide followed by weekly paclitaxel (arm A)
Number of subjects: 2992

Group type: EXPERIMENTAL
Intervention: Paclitaxel then trastuzumab (arm B)
Number of subjects: 2992

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus trastuzumab then trastuzumab alone (arm C)
Number of subjects: 2992
Study: 16913243

Group type: EXPERIMENTAL
Intervention: 10% povidone iodine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Phosphate buffered saline (control)
Number of subjects: 22
Study: 15071257

Group type: EXPERIMENTAL
Intervention: Fluindione (anticoagulant) and aspirin (100 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10878627

Group type: EXPERIMENTAL
Intervention: BeStent small
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: NIR‐7
Number of subjects: 96
Study: 8770380

Group type: EXPERIMENTAL
Intervention: Biofeedback training of voluntary control of respiratory resistance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Externally added flow resistive loads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bronchoconstriction provoked by allergic agents
Number of subjects: 0
Study: 1308247

Group type: EXPERIMENTAL
Intervention: 75 mg/kg Triclofos elixir (Regimen I)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 50 mg/kg Trichlofos elixir combined with 1 mg/kg promethazine elixir (Regimen II)
Number of subjects: 26
Study: 6363930

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg) administered orally on a weekly basis and at the completion of training
Number of subjects: 940

Group type: COMPARATOR
Intervention: Placebo administered orally on a weekly basis and at the completion of training
Number of subjects: 940
Study: 29500585

Group type: EXPERIMENTAL
Intervention: Oxazepam 10 mg (OXA10)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg (DIA10)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Oxazepam 30 mg (OXA30)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neurocognitive tests (various)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neurocognitive tests (ANT, DAT, PVT)
Number of subjects: 23
Study: 27930706

Group type: EXPERIMENTAL
Intervention: Acute Aerobic Exercise (AAE) at low intensity (45-50% max heart rate) for 35 minutes
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Acute Aerobic Exercise (AAE) at moderate intensity (65-70% max heart rate) for 35 minutes
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Acute Aerobic Exercise (AAE) at high intensity (85-90% max heart rate) for 35 minutes
Number of subjects: 121

Group type: COMPARATOR
Intervention: Self-Myofascial Release Training (control group) for 35 minutes
Number of subjects: 121
Study: 24962230

Group type: EXPERIMENTAL
Intervention: Telephone screening tool for SD/tremor
Number of subjects: 39
Study: 22584959

Group type: EXPERIMENTAL
Intervention: Windbreaker jacket and pants
Number of subjects: 9

Group type: COMPARATOR
Intervention: No additional clothing (control group)
Number of subjects: 9
Study: 20492296

Group type: EXPERIMENTAL
Intervention: Heme-iron concentrate (HIC)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Iron sulfate (IS)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo control (PC)
Number of subjects: 112
Study: 17663610

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 461

Group type: COMPARATOR
Intervention: Counseling as Usual (CAU)
Number of subjects: 461
Study: 16194202

Group type: EXPERIMENTAL
Intervention: Ximelagatran (24-60 mg b.i.d)
Number of subjects: 518

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study: 11807406

Group type: EXPERIMENTAL
Intervention: Gene therapy for X‐linked severe combined immunodeficiency (SCID‐X1)
Number of subjects: 0
Study: 10725989

Group type: COMPARATOR
Intervention: Placebo group (control)
Number of subjects: 41
Study: 7491887

Group type: EXPERIMENTAL
Intervention: Calcium‐ and sulfate‐rich mineral water (CS‐W) containing 11.2 mmol Ca/L (467 mg/L)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Milk
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Calcium‐ and sulfate‐rich mineral water (CS‐W)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Calcium‐and sulfate‐rich mineral water (CS‐W)
Number of subjects: 9
Study: 1686339

Group type: EXPERIMENTAL
Intervention: Combination of tetrazepam and a nonsteroid analgetic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonsteroid analgetic
Number of subjects: 60
Study: 7019641

Group type: EXPERIMENTAL
Intervention: Terbutaline sulphate 0.5 mg via metered aerosol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Orally administered theophylline 5 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of terbutaline and theophylline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Metered aerosol alone
Number of subjects: 12
Study: 30889034

Group type: EXPERIMENTAL
Intervention: Electronic administration via REDCap or PelvicTrack App
Number of subjects: 234

Group type: COMPARATOR
Intervention: Paper administration
Number of subjects: 234
Study: 31494376

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 28659278

Group type: EXPERIMENTAL
Intervention: Pathologists' interpretations of melanocytic skin lesions
Number of subjects: 240

Group type: COMPARATOR
Intervention: Consensus diagnosis of experienced pathologists
Number of subjects: 240
Study: 26347428

Group type: EXPERIMENTAL
Intervention: Language for Learning intervention (18 1-hour home-based therapy sessions)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Language for Learning intervention
Number of subjects: 200
Study: 23472619

Group type: EXPERIMENTAL
Intervention: 20-mg memantine
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study: 20824769

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 422
Study: 19631774

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU/day
Number of subjects: 95

Group type: COMPARATOR
Intervention: Ergocalciferol 1000 IU/day
Number of subjects: 95
Study: 17374671

Group type: EXPERIMENTAL
Intervention: Sprinkles‐WSB (S‐WSB)
Number of subjects: 415

Group type: COMPARATOR
Intervention: WSB only (WSB)
Number of subjects: 415